Microbiome and immuno-metabolic dysregulation in patients with major depressive disorder with atypical clinical presentation.
Refisch A, Sen ZD, Klassert TE, Busch A, Besteher B, Danyeli LV, Helbing D, Schulze-Späte U, Stallmach A, Bauer M, Panagiotou G, Jacobsen ID, Slevogt H, Opel N, Walter M.
Refisch A, et al. Among authors: slevogt h.
Neuropharmacology. 2023 Sep 1;235:109568. doi: 10.1016/j.neuropharm.2023.109568. Epub 2023 May 12.
Neuropharmacology. 2023.
PMID: 37182790
Free article.
Review.